The global Short Bowel Syndrome Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Short Bowel Syndrome Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Short Bowel Syndrome Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Short Bowel Syndrome Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome Drugs. This report contains market size and forecasts of Short Bowel Syndrome Drugs in global, including the following market information:
- Global Short Bowel Syndrome Drugs Market Revenue, 2019-2024, 2024-2029, ($ millions)
- Global Short Bowel Syndrome Drugs Market Sales, 2019-2024, 2024-2029, (K Pcs)
- Global top five Short Bowel Syndrome Drugs companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Short Bowel Syndrome Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Short Bowel Syndrome Drugs include Emmaus Medical, Merck, Takeda, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, GLyPharma Therapeutic and Sancilio Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Short Bowel Syndrome Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Short Bowel Syndrome Drugs Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Short Bowel Syndrome Drugs Market Segment Percentages, by Type, 2023 (%)
- Oral Short Bowel Syndrome Drugs
- Tablet Short Bowel Syndrome Drugs
Global Short Bowel Syndrome Drugs Market, by Sale Channel, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Short Bowel Syndrome Drugs Market Segment Percentages, by Sale Channel, 2023 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Short Bowel Syndrome Drugs Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Short Bowel Syndrome Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Short Bowel Syndrome Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Short Bowel Syndrome Drugs revenues share in global market, 2023 (%)
- Key companies Short Bowel Syndrome Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
- Key companies Short Bowel Syndrome Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Emmaus Medical
- Merck
- Takeda
- Ardelyx
- Naia Pharmaceuticals
- Nutrinia
- OxThera
- GLyPharma Therapeutic
- Sancilio Pharmaceuticals
- Zealand Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Short Bowel Syndrome Drugs, market overview.
Chapter 2: Global Short Bowel Syndrome Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Short Bowel Syndrome Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by sale channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Short Bowel Syndrome Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Short Bowel Syndrome Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Short Bowel Syndrome Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sale Channel
1.3 Global Short Bowel Syndrome Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Short Bowel Syndrome Drugs Overall Market Size
2.1 Global Short Bowel Syndrome Drugs Market Size: 2022 VS 2031
2.2 Global Short Bowel Syndrome Drugs Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Short Bowel Syndrome Drugs Sales: 2019-2031
3 Company Landscape
3.1 Top Short Bowel Syndrome Drugs Players in Global Market
3.2 Top Global Short Bowel Syndrome Drugs Companies Ranked by Revenue
3.3 Global Short Bowel Syndrome Drugs Revenue by Companies
3.4 Global Short Bowel Syndrome Drugs Sales by Companies
3.5 Global Short Bowel Syndrome Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Short Bowel Syndrome Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Short Bowel Syndrome Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Short Bowel Syndrome Drugs Players in Global Market
3.8.1 List of Global Tier 1 Short Bowel Syndrome Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Short Bowel Syndrome Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Short Bowel Syndrome Drugs Market Size Markets, 2022 & 2031
4.1.2 Oral Short Bowel Syndrome Drugs
4.1.3 Tablet Short Bowel Syndrome Drugs
4.2 By Type - Global Short Bowel Syndrome Drugs Revenue & Forecasts
4.2.1 By Type - Global Short Bowel Syndrome Drugs Revenue, 2019-2024
4.2.2 By Type - Global Short Bowel Syndrome Drugs Revenue, 2024-2031
4.2.3 By Type - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
4.3 By Type - Global Short Bowel Syndrome Drugs Sales & Forecasts
4.3.1 By Type - Global Short Bowel Syndrome Drugs Sales, 2019-2024
4.3.2 By Type - Global Short Bowel Syndrome Drugs Sales, 2024-2031
4.3.3 By Type - Global Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
4.4 By Type - Global Short Bowel Syndrome Drugs Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Sale Channel
5.1 Overview
5.1.1 By Sale Channel - Global Short Bowel Syndrome Drugs Market Size, 2022 & 2031
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Sale Channel - Global Short Bowel Syndrome Drugs Revenue & Forecasts
5.2.1 By Sale Channel - Global Short Bowel Syndrome Drugs Revenue, 2019-2024
5.2.2 By Sale Channel - Global Short Bowel Syndrome Drugs Revenue, 2024-2031
5.2.3 By Sale Channel - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
5.3 By Sale Channel - Global Short Bowel Syndrome Drugs Sales & Forecasts
5.3.1 By Sale Channel - Global Short Bowel Syndrome Drugs Sales, 2019-2024
5.3.2 By Sale Channel - Global Short Bowel Syndrome Drugs Sales, 2024-2031
5.3.3 By Sale Channel - Global Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
5.4 By Sale Channel - Global Short Bowel Syndrome Drugs Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Short Bowel Syndrome Drugs Market Size, 2022 & 2031
6.2 By Region - Global Short Bowel Syndrome Drugs Revenue & Forecasts
6.2.1 By Region - Global Short Bowel Syndrome Drugs Revenue, 2019-2024
6.2.2 By Region - Global Short Bowel Syndrome Drugs Revenue, 2024-2031
6.2.3 By Region - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
6.3 By Region - Global Short Bowel Syndrome Drugs Sales & Forecasts
6.3.1 By Region - Global Short Bowel Syndrome Drugs Sales, 2019-2024
6.3.2 By Region - Global Short Bowel Syndrome Drugs Sales, 2024-2031
6.3.3 By Region - Global Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Short Bowel Syndrome Drugs Revenue, 2019-2031
6.4.2 By Country - North America Short Bowel Syndrome Drugs Sales, 2019-2031
6.4.3 US Short Bowel Syndrome Drugs Market Size, 2019-2031
6.4.4 Canada Short Bowel Syndrome Drugs Market Size, 2019-2031
6.4.5 Mexico Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Short Bowel Syndrome Drugs Revenue, 2019-2031
6.5.2 By Country - Europe Short Bowel Syndrome Drugs Sales, 2019-2031
6.5.3 Germany Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5.4 France Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5.5 U.K. Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5.6 Italy Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5.7 Russia Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5.8 Nordic Countries Short Bowel Syndrome Drugs Market Size, 2019-2031
6.5.9 Benelux Short Bowel Syndrome Drugs Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Short Bowel Syndrome Drugs Revenue, 2019-2031
6.6.2 By Region - Asia Short Bowel Syndrome Drugs Sales, 2019-2031
6.6.3 China Short Bowel Syndrome Drugs Market Size, 2019-2031
6.6.4 Japan Short Bowel Syndrome Drugs Market Size, 2019-2031
6.6.5 South Korea Short Bowel Syndrome Drugs Market Size, 2019-2031
6.6.6 Southeast Asia Short Bowel Syndrome Drugs Market Size, 2019-2031
6.6.7 India Short Bowel Syndrome Drugs Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Short Bowel Syndrome Drugs Revenue, 2019-2031
6.7.2 By Country - South America Short Bowel Syndrome Drugs Sales, 2019-2031
6.7.3 Brazil Short Bowel Syndrome Drugs Market Size, 2019-2031
6.7.4 Argentina Short Bowel Syndrome Drugs Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales, 2019-2031
6.8.3 Turkey Short Bowel Syndrome Drugs Market Size, 2019-2031
6.8.4 Israel Short Bowel Syndrome Drugs Market Size, 2019-2031
6.8.5 Saudi Arabia Short Bowel Syndrome Drugs Market Size, 2019-2031
6.8.6 UAE Short Bowel Syndrome Drugs Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Emmaus Medical
7.1.1 Emmaus Medical Company Summary
7.1.2 Emmaus Medical Business Overview
7.1.3 Emmaus Medical Short Bowel Syndrome Drugs Major Product Offerings
7.1.4 Emmaus Medical Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Emmaus Medical Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Short Bowel Syndrome Drugs Major Product Offerings
7.2.4 Merck Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Short Bowel Syndrome Drugs Major Product Offerings
7.3.4 Takeda Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Takeda Key News & Latest Developments
7.4 Ardelyx
7.4.1 Ardelyx Company Summary
7.4.2 Ardelyx Business Overview
7.4.3 Ardelyx Short Bowel Syndrome Drugs Major Product Offerings
7.4.4 Ardelyx Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Ardelyx Key News & Latest Developments
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Company Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Major Product Offerings
7.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Naia Pharmaceuticals Key News & Latest Developments
7.6 Nutrinia
7.6.1 Nutrinia Company Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Short Bowel Syndrome Drugs Major Product Offerings
7.6.4 Nutrinia Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Nutrinia Key News & Latest Developments
7.7 OxThera
7.7.1 OxThera Company Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Short Bowel Syndrome Drugs Major Product Offerings
7.7.4 OxThera Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.7.5 OxThera Key News & Latest Developments
7.8 GLyPharma Therapeutic
7.8.1 GLyPharma Therapeutic Company Summary
7.8.2 GLyPharma Therapeutic Business Overview
7.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Major Product Offerings
7.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.8.5 GLyPharma Therapeutic Key News & Latest Developments
7.9 Sancilio Pharmaceuticals
7.9.1 Sancilio Pharmaceuticals Company Summary
7.9.2 Sancilio Pharmaceuticals Business Overview
7.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Major Product Offerings
7.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Sancilio Pharmaceuticals Key News & Latest Developments
7.10 Zealand Pharma
7.10.1 Zealand Pharma Company Summary
7.10.2 Zealand Pharma Business Overview
7.10.3 Zealand Pharma Short Bowel Syndrome Drugs Major Product Offerings
7.10.4 Zealand Pharma Short Bowel Syndrome Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Zealand Pharma Key News & Latest Developments
8 Global Short Bowel Syndrome Drugs Production Capacity, Analysis
8.1 Global Short Bowel Syndrome Drugs Production Capacity, 2019-2031
8.2 Short Bowel Syndrome Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Short Bowel Syndrome Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Short Bowel Syndrome Drugs Supply Chain Analysis
10.1 Short Bowel Syndrome Drugs Industry Value Chain
10.2 Short Bowel Syndrome Drugs Upstream Market
10.3 Short Bowel Syndrome Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Short Bowel Syndrome Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Short Bowel Syndrome Drugs in Global Market
Table 2. Top Short Bowel Syndrome Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Short Bowel Syndrome Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Short Bowel Syndrome Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Short Bowel Syndrome Drugs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Short Bowel Syndrome Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Short Bowel Syndrome Drugs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Short Bowel Syndrome Drugs Product Type
Table 9. List of Global Tier 1 Short Bowel Syndrome Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Short Bowel Syndrome Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2019-2024
Table 15. By Type - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2024-2031
Table 16. By Sale Channel ? Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022 & 2031
Table 17. By Sale Channel - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Sale Channel - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2024-2031
Table 19. By Sale Channel - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2019-2024
Table 20. By Sale Channel - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2024-2031
Table 21. By Region ? Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2019-2024
Table 25. By Region - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2024-2031
Table 26. By Country - North America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Short Bowel Syndrome Drugs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Short Bowel Syndrome Drugs Sales, (K Pcs), 2024-2031
Table 30. By Country - Europe Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Short Bowel Syndrome Drugs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Short Bowel Syndrome Drugs Sales, (K Pcs), 2024-2031
Table 34. By Region - Asia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Short Bowel Syndrome Drugs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Short Bowel Syndrome Drugs Sales, (K Pcs), 2024-2031
Table 38. By Country - South America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Short Bowel Syndrome Drugs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Short Bowel Syndrome Drugs Sales, (K Pcs), 2024-2031
Table 42. By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales, (K Pcs), 2024-2031
Table 46. Emmaus Medical Company Summary
Table 47. Emmaus Medical Short Bowel Syndrome Drugs Product Offerings
Table 48. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. Emmaus Medical Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Short Bowel Syndrome Drugs Product Offerings
Table 52. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. Merck Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Short Bowel Syndrome Drugs Product Offerings
Table 56. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. Takeda Key News & Latest Developments
Table 58. Ardelyx Company Summary
Table 59. Ardelyx Short Bowel Syndrome Drugs Product Offerings
Table 60. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Ardelyx Key News & Latest Developments
Table 62. Naia Pharmaceuticals Company Summary
Table 63. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Offerings
Table 64. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. Naia Pharmaceuticals Key News & Latest Developments
Table 66. Nutrinia Company Summary
Table 67. Nutrinia Short Bowel Syndrome Drugs Product Offerings
Table 68. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Nutrinia Key News & Latest Developments
Table 70. OxThera Company Summary
Table 71. OxThera Short Bowel Syndrome Drugs Product Offerings
Table 72. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. OxThera Key News & Latest Developments
Table 74. GLyPharma Therapeutic Company Summary
Table 75. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Offerings
Table 76. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. GLyPharma Therapeutic Key News & Latest Developments
Table 78. Sancilio Pharmaceuticals Company Summary
Table 79. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Offerings
Table 80. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Sancilio Pharmaceuticals Key News & Latest Developments
Table 82. Zealand Pharma Company Summary
Table 83. Zealand Pharma Short Bowel Syndrome Drugs Product Offerings
Table 84. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Zealand Pharma Key News & Latest Developments
Table 86. Short Bowel Syndrome Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2024 (K Pcs)
Table 87. Global Short Bowel Syndrome Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 88. Global Short Bowel Syndrome Drugs Production by Region, 2019-2024 (K Pcs)
Table 89. Global Short Bowel Syndrome Drugs Production by Region, 2024-2031 (K Pcs)
Table 90. Short Bowel Syndrome Drugs Market Opportunities & Trends in Global Market
Table 91. Short Bowel Syndrome Drugs Market Drivers in Global Market
Table 92. Short Bowel Syndrome Drugs Market Restraints in Global Market
Table 93. Short Bowel Syndrome Drugs Raw Materials
Table 94. Short Bowel Syndrome Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Short Bowel Syndrome Drugs Downstream
Table 96. Short Bowel Syndrome Drugs Downstream Clients in Global Market
Table 97. Short Bowel Syndrome Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Short Bowel Syndrome Drugs Segment by Type in 2022
Figure 2. Short Bowel Syndrome Drugs Segment by Sale Channel in 2022
Figure 3. Global Short Bowel Syndrome Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Short Bowel Syndrome Drugs Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Short Bowel Syndrome Drugs Revenue, 2019-2031 (US$, Mn)
Figure 7. Short Bowel Syndrome Drugs Sales in Global Market: 2019-2031 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Short Bowel Syndrome Drugs Revenue in 2022
Figure 9. By Type - Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 11. By Type - Global Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 12. By Type - Global Short Bowel Syndrome Drugs Price (USD/Pcs), 2019-2031
Figure 13. By Sale Channel - Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Sale Channel - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 15. By Sale Channel - Global Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 16. By Sale Channel - Global Short Bowel Syndrome Drugs Price (USD/Pcs), 2019-2031
Figure 17. By Region - Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 20. By Region - Global Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 21. By Country - North America Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 22. By Country - North America Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 23. US Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 28. Germany Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 29. France Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 37. China Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 41. India Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 43. By Country - South America Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 44. Brazil Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales Market Share, 2019-2031
Figure 48. Turkey Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2019-2031
Figure 52. Global Short Bowel Syndrome Drugs Production Capacity (K Pcs), 2019-2031
Figure 53. The Percentage of Production Short Bowel Syndrome Drugs by Region, 2022 VS 2031
Figure 54. Short Bowel Syndrome Drugs Industry Value Chain
Figure 55. Marketing Channels
